With the extremely successful launch of Vyndamax for the treatment of patients with transthyretin amyloid cardiomyopathy (ATTR-CM), Pfizer has established Vyndamax as the global leader in the field of amyloidosis. Vyndamax is a US Commercial priority and the anchor brand for the Specialty Care. With two new competitive entrants and an additional potential entrant expected in early 2027, positioning Vyn for continued leadership is critical for Pfizer. As the brand advances through its lifecycle, sustained performance will require strong strategic planning, operational execution and disciplined investment management. The team operates in a highly matrixed environment, partnering closely with analytics, media, customer engagement, and enterprise teams to translate insight into action and deliver strong commercial outcomes. This role will report to the Vyndamax HCP Competitive and LCM Lead.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level